Literature DB >> 1456277

Ondansetron: pharmacology of a specific 5HT3-receptor antagonist.

R Deegan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1456277     DOI： 10.1097/00000441-199212000-00009

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  4 in total

Review 1.  Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications.

Authors:  M I Wilde; A Markham
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

Review 2.  Volunteer models for predicting antiemetic activity of 5-HT3-receptor antagonists.

Authors:  N A Minton
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

3.  Prevention of microemulsion propofol injection pain: a comparison of a combination of lidocaine and ramosetron with lidocaine or ramosetron alone.

Authors:  Hyun-Young Lee; Sang-Hun Kim; Keum-Young So
Journal:  Korean J Anesthesiol       Date:  2011-07-21

4.  Effect of adding 8 milligrams ondansetron to lidocaine for Bier's block on post-operative pain.

Authors:  Azim Honarmand; Mohammadreza Safavi; Leili Adineh-Mehr
Journal:  Adv Biomed Res       Date:  2013-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.